Celebrating Significant Progress in Orthopedic Research
Force Therapeutics proudly commemorates a remarkable year in research driven by fruitful collaborations with healthcare partners. These partnerships have laid the groundwork for pioneering studies aimed at enhancing orthopedic care. The utilization of Force Therapeutics' outcomes data coupled with a robust research framework has significantly contributed to advancing medical knowledge and practices.
Key Achievements in 2025
In 2025, numerous research initiatives partnered with Force were either published or presented in prestigious academic forums. These ventures have illustrated the vital role of real-world digital care data in transforming orthopedics. They highlight the possibilities that emerge when healthcare providers have access to high-quality patient-reported outcomes and comprehensive engagement metrics.
Notable Publications and Presentations
Throughout the year, several key presentations and research articles garnered attention. These include:
- Current Concepts in Joint Replacement Meeting: A poster examined the comparative pain levels in patients undergoing total hip versus total knee arthroplasty.
- FrameWORX - Musculoskeletal Advancements: Researchers presented findings on the impact of cumulative patient comorbidities on 90-day readmission rates following joint surgeries.
- Journal of Orthopedic Reports: An article disclosed insights into preoperative indicators that could lead to unplanned emergency room visits after total hip arthroplasty.
- Journal of the American Academy of Orthopedic Surgeons: A study found that patient satisfaction rates post hip arthroplasty can reach as high as 95%.
- American Association of Hip and Knee Surgeons Annual Meeting: A poster highlighted the trend of patients pursuing bilateral joint surgeries with lower preoperative discomfort levels.
- National Association of Orthopedic Nurses Congress: A podium presentation revealed that nearly 90% of knee arthroplasty patients report satisfaction, showing improvements in care standards.
- Western Orthopedic Association Meeting: An e-poster focused on how a digital patient engagement platform complies with Medicare's requirements following total hip or knee arthroplasty.
- Northeast Arthroplasty Conference: Multiple posters shared findings on patient satisfaction and preoperative predictors of complications, earning accolades for their impactful content.
A Commitment to Patient-Centric Research
Amid these successes, Bronwyn Spira, CEO and Founder of Force Therapeutics, remarked, "These publications exhibit our partners' unwavering commitment to their patients. Their leadership and dedication to improving care make a significant difference in the healthcare landscape, turning data into insights and insights into meaningful impact."
Force Therapeutics continues to lead the way in research dedicated to improving real-world medical practices and enriching patient experiences. The inspiring work demonstrated by our partners each day illustrates the results achieved when digital care is executed with understanding and integrity.
Frequently Asked Questions
What is the primary focus of Force Therapeutics?
Force Therapeutics focuses on enhancing orthopedic patient care through data-driven research and collaborations with healthcare providers.
How has Force contributed to orthopedic research?
Through partnerships, Force has enabled numerous impactful studies that improve patient outcomes and provide insights into orthopedic practices.
What kind of studies were presented in 2025?
In 2025, studies included topics on pain management in surgeries, patient satisfaction rates, and factors influencing emergency visits post-surgery.
Who leads Force Therapeutics?
Bronwyn Spira is the CEO and Founder of Force Therapeutics, guiding the company's vision and research initiatives.
What does the future hold for Force Therapeutics?
Looking ahead, Force Therapeutics aims to continue advancing research and collaborations that enhance patient care in orthopedics.
